Why the study?
To evaluate the clinical efficacy of cardiac contractility modulation in patients with chronic heart failure and various forms of atrial fibrillation.
Does cardiac contractility modulation improve functional capacity, quality of life, and reverse remodeling in patients with HFrEF and atrial fibrillation?
Does cardiac contractility modulation improve functional capacity, quality of life, and reverse remodeling in patients with HFrEF and atrial fibrillation?
Cardiac contractility modulation improves functional status, quality of life, and promotes reverse left ventricular remodeling without increasing arrhythmia burden in patients with HFrEF and atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sharapova et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: